SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Lobbying for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Feb 11, 2026

Expenses

$80,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 4

Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Nuclear Regulatory Commission (NRC)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 3

S 1410
Find It Early Act
HR 2541
Nuclear Medicine Clarification Act of 2025
HR 879
Medicare Patient Access and Practice Stabilization Act of 2025

Lobbying activity 3

Health Issues

Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.

Budget/Appropriations

Theranostics report language in the FY26 Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.

Medicare/Medicaid

Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.